| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/31/2014 | WO2014117001A1 Tetrazines/trans-cyclooctenes in solid phase synthesis of labeled peptides |
| 07/31/2014 | WO2014116865A1 Methods and materials for detecting c9orf72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or c9orf72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis |
| 07/31/2014 | WO2014116846A2 Methods and compositions for modulating an immune response |
| 07/31/2014 | WO2014116789A1 Immunogenic and prophylactic compositions, methods of making same, and method for treating and preventing tnf-mediated disease and hiv-1 infection |
| 07/31/2014 | WO2014116596A1 Methods for optimizing domain stability of binding proteins |
| 07/31/2014 | WO2014116184A1 Angiopoietin-related protein 4 (cangptl4) as a diagnostic biomarker for acute lung damage |
| 07/31/2014 | WO2014114801A1 Antibodies targeting cdh19 for melanoma |
| 07/31/2014 | WO2014114800A1 Antibody constructs for cdh19 and cd3 |
| 07/31/2014 | WO2014114780A1 Method and kit for detecting 1,25-dihydroxyvitamin d and related antibodies |
| 07/31/2014 | WO2014114651A1 Tnf-alpha antigen-binding proteins |
| 07/31/2014 | WO2014114298A1 Mfap4 binding antibodies blocking the interaction between mfap4 and integrin receptors |
| 07/31/2014 | WO2014106116A3 Therapeutic compositions comprising antibodies |
| 07/31/2014 | WO2014083040A3 Progranulin as marker for autoimmune disorders |
| 07/31/2014 | WO2014072720A3 Cell differentiation |
| 07/31/2014 | WO2014071212A3 Stable dual variable domain immunoglobulin protein formulations |
| 07/31/2014 | WO2013063186A3 Monoclonal antibodies and methods of use |
| 07/31/2014 | US20140213774 Process for Obtaining Immunoglobulins from Colostral Milk |
| 07/31/2014 | US20140213773 Adam6 mice |
| 07/31/2014 | US20140213772 Cross-over dual variable domain immunoglobulin constructs |
| 07/31/2014 | US20140213771 Multi-specific binding proteins |
| 07/31/2014 | US20140213770 High-throughput antibody humanization |
| 07/31/2014 | US20140213769 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 07/31/2014 | US20140213768 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 07/31/2014 | US20140213604 Protein kinase c as a target for the treatment of respiratory syncytial virus |
| 07/31/2014 | US20140213511 Compositions and methods of use for treating metabolic disorders |
| 07/31/2014 | US20140213459 Antibodies with improved folding stability |
| 07/31/2014 | US20140212946 Non-natural ribonuclease conjugates as cytotoxic agents |
| 07/31/2014 | US20140212925 Il-1 binding proteins |
| 07/31/2014 | US20140212897 Methods for predicting pregnancy outcome in a subject by hcg assay |
| 07/31/2014 | US20140212896 Methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis |
| 07/31/2014 | US20140212888 T cell receptor and uses thereof |
| 07/31/2014 | US20140212481 Immunological methods and compositions for the treatment of alzheimer's disease |
| 07/31/2014 | US20140212451 Lyme Disease Vaccine |
| 07/31/2014 | US20140212447 Rift Valley Fever Virus Glycoproteins, GN and GC, and their Use |
| 07/31/2014 | US20140212439 Anti-EPHA2 Antibody |
| 07/31/2014 | US20140212438 Nuclear targeting sequences |
| 07/31/2014 | US20140212437 Methods and compositions for treating atrial fibrillation |
| 07/31/2014 | US20140212436 Rapid clearance of antigen complexes using novel antibodies |
| 07/31/2014 | US20140212435 Rapid clearance of antigen complexes using novel antibodies |
| 07/31/2014 | US20140212433 Humanized Anti-Factor D Antibodies And Uses Thereof |
| 07/31/2014 | US20140212432 Antibodies Specific for Urokinase-Type Plasminogen Activator and Methods of Use Thereof |
| 07/31/2014 | US20140212431 Pcsk9-binding polypeptides and methods of use |
| 07/31/2014 | US20140212430 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 07/31/2014 | US20140212429 Binding members-513 |
| 07/31/2014 | US20140212428 Human il-23 antigen binding proteins |
| 07/31/2014 | US20140212427 Anti-Properdin Antibodies and Uses Thereof |
| 07/31/2014 | US20140212426 Toll-Like Receptor 3 Antagonists |
| 07/31/2014 | US20140212425 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 07/31/2014 | US20140212424 Anti-tnf-alpha antibodies and their uses |
| 07/31/2014 | US20140212423 Blood-brain barrier penetrating dual specific binding proteins |
| 07/31/2014 | US20140212418 Therapeutic Antibodies |
| 07/31/2014 | US20140212417 Prolonged inhibition of interleukin-6 mediated signaling |
| 07/31/2014 | US20140212416 Manipulation of Immunoglobulin Gene Diversity and Multi-Antibody Therapeutics |
| 07/31/2014 | US20140212414 Combination therapy using p53 activator and c-met inhibitor |
| 07/31/2014 | US20140212413 Methods of Treating TNF-alpha-Mediated Diseases Using Chimeric TNF-alpha Antibodies |
| 07/31/2014 | US20140212412 Use of il-33 antagonists to treat fibrotic disease |
| 07/31/2014 | US20140212409 METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL SURFACE AND PHAGOCYTOSIS BY PHAGOCYTE AND A THERAPEUTIC METHOD AND A THERAPEUTIC AGENT FOR BACTERIAL INFECTIONS |
| 07/31/2014 | US20140212408 Anti-CEA Antibodies |
| 07/31/2014 | US20140212407 Treatment of obesity |
| 07/31/2014 | US20140212379 Il-1 binding proteins |
| 07/30/2014 | EP2759551A1 Antibody against affinity complex |
| 07/30/2014 | EP2759550A1 Method and kit for detecting 1,25-dihydroxyvitamin D and related antibodies |
| 07/30/2014 | EP2759549A2 IL-31 monoclonal antibodies and methods of use |
| 07/30/2014 | EP2759297A1 Combination therapy using p53 activator and c-Met inhibitor |
| 07/30/2014 | EP2758535A2 Antibodies, variable domains&chains tailored for human use |
| 07/30/2014 | EP2758534A2 Animals, repertoires & methods for the production of human antibodies |
| 07/30/2014 | EP2758438A1 Bispecific binding molecules for 5t4 and cd3 |
| 07/30/2014 | EP2758437A2 Cd27l antigen binding proteins |
| 07/30/2014 | EP2758436A1 Serum half-life extension using immunoglobulin binding domains |
| 07/30/2014 | EP2758435A1 Bispecific anti-egfr/anti igf-1r antibodies |
| 07/30/2014 | EP2758434A2 Anti-tumor necrosis factor-alpha agents and uses thereof |
| 07/30/2014 | EP2758433A1 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 07/30/2014 | EP2758432A1 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile |
| 07/30/2014 | EP2758431A1 Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site |
| 07/30/2014 | EP2758430A1 Anti-c-met antibodies |
| 07/30/2014 | EP2758429A1 Removal of virucidal agents from biomolecule preparations |
| 07/30/2014 | EP2758428A1 METHOD FOR OBTAINING FAB FRAGMENTS FROM SINGLE ANTIBODY PRODUCING CELLS BY MULTIPLEXED PCR IN COMBINATION WITH TaqMan PROBES |
| 07/30/2014 | EP2758422A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 07/30/2014 | EP2758079A1 Methods using liver disease biomarkers |
| 07/30/2014 | EP2758077A2 Compounds for use in the treatment of alzheimer's disease |
| 07/30/2014 | EP2758073A1 Vegf/dll4 binding agents and uses thereof |
| 07/30/2014 | EP2757875A2 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| 07/30/2014 | CN103958679A 变异型α-辅肌动蛋白-4的抗体 Variant α- actinin-4 antibody |
| 07/30/2014 | CN103958547A 具有促进抗原清除的FcRn结合结构域的治疗性抗原结合分子 FcRn binding domain has an antigen to promote clearance of therapeutic antigen-binding molecule |
| 07/30/2014 | CN103958546A 巨噬细胞活化的调节 Regulation of macrophage activation |
| 07/30/2014 | CN103958545A 犬源化肿瘤坏死因子抗体及其使用方法 Dog humanized TNF antibody and method of use |
| 07/30/2014 | CN103958544A 针对艰难梭菌的主要外毒素TcdA和TcdB的中和抗体 For the primary C. difficile exotoxin TcdA and TcdB neutralizing antibodies |
| 07/30/2014 | CN103958543A 治疗肽 Therapeutic peptide |
| 07/30/2014 | CN103958542A 经修饰的白蛋白结合结构域及其用于改善药代动力学的用途 Modified albumin binding domain and used to improve the pharmacokinetics of the use of |
| 07/30/2014 | CN103957938A 治疗多发性骨髓瘤相关障碍的抗icam-1抗体 Treatment of multiple myeloma-related disorders anti-icam-1 antibody |
| 07/30/2014 | CN103957937A 用于治疗阿尔茨海默病的化合物 Compounds for the treatment of Alzheimer's disease |
| 07/30/2014 | CN103954780A 己烯雌酚一步式化学发光酶免疫分析检测法及试剂盒 Diethylstilbestrol-step chemiluminescent assay and enzyme immunoassay kit |
| 07/30/2014 | CN103954749A 一种用于直接检测呋喃它酮代谢物amoz的快速免疫检测方法 A direct detection of furan rapid immunoassay method it used ketone metabolites amoz |
| 07/30/2014 | CN103952427A 人乳头瘤病毒6bE7蛋白表达及应用 Human papilloma virus protein expression and application 6bE7 |
| 07/30/2014 | CN103952389A 水稻Rubisco大亚基抗原表位、其抗体及应用 Rice Rubisco large subunit epitope antibody and its application |
| 07/30/2014 | CN103952383A 水稻胞质型ppdk蛋白抗原表位、其抗体及应用 Rice ppdk cytoplasmic protein epitopes, antibody and its application |
| 07/30/2014 | CN103951755A 抗氯霉素和克伦特罗的双特异性单克隆抗体及其制备方法 Anti-chloramphenicol and clenbuterol bispecific monoclonal antibodies and methods |
| 07/30/2014 | CN103951754A 一种靶向治疗和检测双功能的抗肿瘤双特异性小型化抗体 One kind of targeted therapy and detection bifunctional antitumor bispecific antibody miniaturization |
| 07/30/2014 | CN103951753A 抗-gitr抗体 Anti--gitr antibody |
| 07/30/2014 | CN103951752A 新抗-igf-ir抗体及其用途 The new anti--igf-ir antibodies and uses thereof |